Empowering Biotech Innovation with Advanced Analytical Services
Our Services
Antibody / Bispecific /
Fusion Protein / Enzyme
Discovery Stage
Intact Mass Analysis (HT)
Sequence Coverage and PTM by Peptide Mapping
Size Variant Analysis
Charge Variant Analysis
Development Stage
Developability Assessment
QC Assay Development and Qualification
Process Development Analytics
-
HT Size Variant Analysis
-
HT Charge Variant Analysis
-
HT Glycan Analysis
-
HT Intact Mass Analysis
-
Peptide Mapping
-
Disulfide Mapping
CQA Assessment
In-use Stability Study
Process-related impurity quantitation
Pre-formulation Development
Regulatory Filing and Commercialization Stage
Extended Characterization Study (include Biophysical tools)
Forced Degradation Study
Accelerated Stability Study
Comparability Study
Assay Modernization and Lifetime Management
Antibody Drug Conjugate /
Antibody Oligonucleotide Conjugate
Identity / PTM (Intact Mass, Peptide Mapping)
DAR/OAR Determination (HIC, AEX etc)
Biophysical Characterization (AUC, DSC, CD etc)
Adeno-associated Virus / Adeno Virus /
Lenti Virus / mRNA
Viral Protein
VP Identity / PTM (Intact Mass, Peptide Mapping)
AAV VP Ratio (Intact Mass, CGE & CGE-LIF)
AAV Empty/Full Ratio (AUC, AEX, A260/A280, HIC, SEC-MALS)
Host Cell Protein Analysis (Mass Spectrometry, ELISA)
Process-related impurity Quantitation
SDS-PAGE & Western Blot
Genomic Load
DNA Gel Electrophoresis (Alkaline, Neutral)
DNA Size Distribution (CGE)
Driving Biotech Advancements
SynchroBio seamlessly integrates with your biotech ecosystem, empowering you to harness the full potential of our analytical services and drive meaningful advancements in the biotechnology field.